<antigenSupportingData>
<immunity>
<clinicalHistory>
<guidelineCode>019</guidelineCode>
<guidelineTitle>Laboratory Evidence of Immunity or confirmation of Hepatitis B disease</guidelineTitle>
</clinicalHistory>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>097</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Hepatitis B</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Hepatitis B vaccine.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>110</observationCode>
<observationTitle>Hypersensitivity to yeast</observationTitle>
<contraindicationText>Do not vaccinate if the patient has a hypersensitivity to yeast.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
<vaccine>
<contraindication>
<observationCode>007</observationCode>
<observationTitle>Pregnant</observationTitle>
<contraindicationText>Do not vaccinate if the patient is pregnant.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
<contraindicatedVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
<contraindication>
<observationCode>076</observationCode>
<observationTitle>Progressive neurologic disorder</observationTitle>
<contraindicationText>Do not vaccinate if the patient has progressive neurologic disorder until a treatment regimen has been
established and the condition has stabilized.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
<contraindicatedVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
<contraindication>
<observationCode>079</observationCode>
<observationTitle>Encephalopathy not attributable to another identifiable cause within 7 days of administration of a previous dose of Tdap, DTP, or DTaP vaccine</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had encephalopathy not attributable to another identifiable cause within 7 days of administration of a previous dose of Tdap, DTP, or DTaP vaccine.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
<contraindicatedVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
<contraindication>
<observationCode>107</observationCode>
<observationTitle>Severe allergic reaction to neomycin</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to neomycin.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
<contraindicatedVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
<contraindication>
<observationCode>109</observationCode>
<observationTitle>Severe allergic reaction to polymyxin B</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to polymyxin B. </contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
</vaccine>
</contraindications>
<series>
<seriesName>HepB 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>0 days</minAge>
<earliestRecAge>0 days</earliestRecAge>
<latestRecAge>4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>4 weeks - 4 days</absMinAge>
<minAge>4 weeks</minAge>
<earliestRecAge>1 month</earliestRecAge>
<latestRecAge>3 months + 4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>5 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge>24 weeks - 4 days</absMinAge>
<minAge>24 weeks</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>19 months + 4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>18 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>0 days</minAge>
<earliestRecAge>0 days</earliestRecAge>
<latestRecAge>4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>4 weeks - 4 days</absMinAge>
<minAge>4 weeks</minAge>
<earliestRecAge>2 months</earliestRecAge>
<latestRecAge>3 months + 4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>5 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>0 days</minInt>
<earliestRecInt>0 days</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge>24 weeks - 4 days</absMinAge>
<minAge>24 weeks</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>19 months + 4 weeks</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>2</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB adolescent 2-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>16 years - 4 months</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>11 years - 4 days</absMinAge>
<minAge>11 years</minAge>
<earliestRecAge>11 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge/>
<endAge/>
<tradeName>RECOMBIVAX ADULT</tradeName>
<mvx>MSD</mvx>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>16 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 months - 4 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge/>
<endAge/>
<tradeName>RECOMBIVAX ADULT</tradeName>
<mvx>MSD</mvx>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB 19+ 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>4</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB Heplisav-B 2-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>5</seriesPreference>
<minAgeToStart>18 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>0 days</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>4 weeks - 4 days</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB Heplisav-B secondary 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>6</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>0 days</minAge>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>0 days</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>2</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>2</fromTargetDose>
<absMinInt>4 weeks - 4 days</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose can be skipped once two doses of Heplisav-B are administered.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>189</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB Heplisav-B tertiary 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>7</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>0 days</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>4 weeks - 4 days</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose can be skipped once two doses of Heplisav-B are administered.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>189</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB Twinrix 3 Dose Series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>8</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>5 months - 4 days</absMinInt>
<minInt>5 months</minInt>
<earliestRecInt>5 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months - 4 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB Twinrix 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>9</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>60 years</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge>60 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>7 days</absMinInt>
<minInt>7 days</minInt>
<earliestRecInt>7 days</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>14 days</absMinInt>
<minInt>14 days</minInt>
<earliestRecInt>14 days</earliestRecInt>
<latestRecInt>23 days</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>12 months - 4 days</absMinInt>
<minInt>12 months</minInt>
<earliestRecInt>12 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>60 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Hepatitis C virus infection</text>
<code>005</code>
</observationCode>
<description>Administer to persons with a hepatitis C virus infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Administer to persons who have diabetes at the discretion of the treating clinician.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Includes, but is not limited to persons with hepatitis C virus (HCV) infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level persistently greater than twice the upper limit of normal </guidance>
</indication>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to persons on maintenance dialysis, including incenter or home hemodialysis and peritoneal dialysis, and persons who are predialysis</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to healthcare personnel.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Heplisav-B 2-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>60 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Hepatitis C virus infection</text>
<code>005</code>
</observationCode>
<description>Administer to persons with a hepatitis C virus infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Administer to persons who have diabetes at the discretion of the treating clinician.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Includes, but is not limited to persons with hepatitis C virus (HCV) infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level persistently greater than twice the upper limit of normal </guidance>
</indication>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to persons on maintenance dialysis, including incenter or home hemodialysis and peritoneal dialysis, and persons who are predialysis</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to healthcare personnel.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>4 weeks - 4 days</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Heplisav-B secondary 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart>60 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Hepatitis C virus infection</text>
<code>005</code>
</observationCode>
<description>Administer to persons with a hepatitis C virus infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Administer to persons who have diabetes at the discretion of the treating clinician.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Includes, but is not limited to persons with hepatitis C virus (HCV) infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level persistently greater than twice the upper limit of normal </guidance>
</indication>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to persons on maintenance dialysis, including incenter or home hemodialysis and peritoneal dialysis, and persons who are predialysis</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to healthcare personnel.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>0 days</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>2</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>2</fromTargetDose>
<absMinInt>4 weeks - 4 days</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose can be skipped once two doses of Heplisav-B are administered.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>189</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Heplisav-B tertiary 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>4</seriesPreference>
<minAgeToStart>60 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Hepatitis C virus infection</text>
<code>005</code>
</observationCode>
<description>Administer to persons with a hepatitis C virus infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Administer to persons who have diabetes at the discretion of the treating clinician.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Includes, but is not limited to persons with hepatitis C virus (HCV) infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level persistently greater than twice the upper limit of normal </guidance>
</indication>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to persons on maintenance dialysis, including incenter or home hemodialysis and peritoneal dialysis, and persons who are predialysis</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to healthcare personnel.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>0 days</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>4 weeks - 4 days</absMinInt>
<effectiveDate/>
<cessationDate/>
</allowableInterval>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose can be skipped once two doses of Heplisav-B are administered.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>189</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Twinrix 3 Dose Series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>5</seriesPreference>
<minAgeToStart>60 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Hepatitis C virus infection</text>
<code>005</code>
</observationCode>
<description>Administer to persons with a hepatitis C virus infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Administer to persons who have diabetes at the discretion of the treating clinician.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Includes, but is not limited to persons with hepatitis C virus (HCV) infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level persistently greater than twice the upper limit of normal </guidance>
</indication>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to persons on maintenance dialysis, including incenter or home hemodialysis and peritoneal dialysis, and persons who are predialysis</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to  healthcare personnel.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>5 months - 4 days</absMinInt>
<minInt>5 months</minInt>
<earliestRecInt>5 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months - 4 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Twinrix 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>6</seriesPreference>
<minAgeToStart>60 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Hepatitis C virus infection</text>
<code>005</code>
</observationCode>
<description>Administer to persons with a hepatitis C virus infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Administer to persons who have diabetes at the discretion of the treating clinician.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance>Includes, but is not limited to persons with hepatitis C virus (HCV) infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level persistently greater than twice the upper limit of normal </guidance>
</indication>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to persons on maintenance dialysis, including incenter or home hemodialysis and peritoneal dialysis, and persons who are predialysis</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to  healthcare personnel.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>60 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>7 days</absMinInt>
<minInt>7 days</minInt>
<earliestRecInt>7 days</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>14 days</absMinInt>
<minInt>14 days</minInt>
<earliestRecInt>14 days</earliestRecInt>
<latestRecInt>23 days</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>12 months - 4 days</absMinInt>
<minInt>12 months</minInt>
<earliestRecInt>12 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Dialysis 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Test all vaccinees for anti-HBs 1-2 months after the last primary vaccine dose, to determine their response to the vaccine (adequate response is defined as at least 10 mIU/mL). Patients and staff members who do not respond to the primary vaccine series should be revaccinated with three additional doses and retested for response. No additional series should be administered (i.e., a 3rd full series). The patient should receive yearly boosters starting 1 year after completion of the second series.</seriesAdminGuidance>
<seriesAdminGuidance>Retest patients who respond to the vaccine annually for anti-HBs. If anti-HBs declines to less than 10 mIU/mL, administer a booster dose of hepatitis B vaccine and continue to retest annually. Retesting immediately after the booster dose is not necessary. For staff members who respond to the vaccine, booster doses of vaccine are not necessary, and periodic serologic testing to monitor antibody concentrations is not recommended</seriesAdminGuidance>
<seriesAdminGuidance>Routine childhood vaccination against hepatitis B has been recommended since 1991 and routine adolescent vaccination since 1995. Thus, many persons who develop end-stage renal failure will have a history of vaccination against hepatitis B. These persons should have responded to the vaccine when their immune status was normal, but if their anti-HBs levels are less than 10 mIU/mL when they begin dialysis, they should be revaccinated with a complete primary series.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>20 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to hemodialysis patients and predialysis, peritoneal dialysis, and home dialysis patients</description>
<beginAge>20 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>20 years</minAge>
<earliestRecAge>20 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>OR</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
<set>
<setID>2</setID>
<setDescription>Dose is not required if patient has received 2 doses of Heplisav-B</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>189</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, adjuvanted</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-hepB-Hib Pentavalent Non-US</vaccineType>
<cvx>198</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB recombinant, 3-antigen, Al(OH)3</vaccineType>
<cvx>220</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>OR</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
<set>
<setID>2</setID>
<setDescription>Dose is not required if patient has received exactly 2 doses of HepB AND both doses were Heplisav-B</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic>AND</conditionLogic>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount>2</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>equal to</doseCountLogic>
<vaccineTypes>08; 42; 43; 44; 45; 51; 102; 104; 110; 132; 146; 189; 198; 220</vaccineTypes>
<seriesGroups/>
</condition>
<condition>
<conditionID>2</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount>2</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>equal to</doseCountLogic>
<vaccineTypes>189</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 5</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>Yes</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>HepB risk Recombivax 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance>Test all vaccinees for anti-HBs 1-2 months after the last primary vaccine dose, to determine their response to the vaccine (adequate response is defined as at least 10 mIU/mL). Patients and staff members who do not respond to the primary vaccine series should be revaccinated with three additional doses and retested for response. No additional series should be administered (i.e., a 3rd full series). The patient should receive yearly boosters starting 1 year after completion of the second series.</seriesAdminGuidance>
<seriesAdminGuidance>Retest patients who respond to the vaccine annually for anti-HBs. If anti-HBs declines to less than 10 mIU/mL, administer a booster dose of hepatitis B vaccine and continue to retest annually. Retesting immediately after the booster dose is not necessary. For staff members who respond to the vaccine, booster doses of vaccine are not necessary, and periodic serologic testing to monitor antibody concentrations is not recommended</seriesAdminGuidance>
<seriesAdminGuidance>Routine childhood vaccination against hepatitis B has been recommended since 1991 and routine adolescent vaccination since 1995. Thus, many persons who develop end-stage renal failure will have a history of vaccination against hepatitis B. These persons should have responded to the vaccine when their immune status was normal, but if their anti-HBs levels are less than 10 mIU/mL when they begin dialysis, they should be revaccinated with a complete primary series.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>20 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Dialysis patient</text>
<code>032</code>
</observationCode>
<description>Administer to hemodialysis patients and predialysis, peritoneal dialysis, and home dialysis patients</description>
<beginAge>20 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>20 years</minAge>
<earliestRecAge>20 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1.0</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepB-CpG</vaccineType>
<cvx>189</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>Yes</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
